Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10751342 Use of inhibitors of Bruton's tyrosine kinase (Btk)

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 22 Jul, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 22 Jul, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=107513420
Edits on 14 Jun, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 14 Jun, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11672803 Use of inhibitors of Brutons tyrosine kinase (Btk)
0
Edits on 24 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 24 Apr, 2023
Edits on 7 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 7 Apr, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
Pharmacyclics
Pharmacyclics
0
Current Assignee
Pharmacyclics
Pharmacyclics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
107513420
Date of Patent
August 25, 2020
0
Patent Application Number
167481420
Date Filed
January 21, 2020
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=107513420
Patent Citations
‌
US Patent 10004745 Use of inhibitors of Bruton'S tyrosine kinase (Btk)
0
‌
US Patent 10004746 Use of inhibitors of Bruton's tyrosine kinase (Btk)
0
‌
US Patent 10010507 Pharmaceutical formulations of a bruton's tyrosine kinase inhibitor
0
‌
US Patent 10016435 Use of inhibitors of Bruton's tyrosine kinase (Btk)
0
‌
US Patent 10213386 Pharmaceutical formulations of a Bruton's tyrosine kinase inhibitor
0
‌
US Patent 10478439 Use of inhibitors of bruton's tyrosine kinase (Btk)
0
Patent Citations Received
‌
US Patent 11433072 Oral dosage forms of ibrutinib
0
Patent Primary Examiner
‌
Umamaheswari Ramachandran
0
Edits on 3 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 3 Apr, 2023
Edits on 2 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 2 Apr, 2023
Edits on 28 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 28 Mar, 2023
Edits on 24 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 24 Mar, 2023
Edits on 27 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 27 Sep, 2022
Edits on 26 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
Edits on 7 Sep, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Sep, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11433072 Oral dosage forms of ibrutinib
Edits on 8 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 8 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=10751342
Edits on 6 Feb, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 6 Feb, 2022
Edits made to:
Infobox (+15 properties)
‌

 US Patent 10751342 Use of inhibitors of Bruton's tyrosine kinase (Btk)

Infobox
Is a
Patent
Patent
Patent applicant
Pharmacyclics
Pharmacyclics
Current assignee
Pharmacyclics
Pharmacyclics
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
10751342
Date of patent
August 25, 2020
Patent application number
16748142
Date Filed
January 21, 2020
Patent citations
‌
US Patent 10004745 Use of inhibitors of Bruton'S tyrosine kinase (Btk)
‌
US Patent 10004746 Use of inhibitors of Bruton's tyrosine kinase (Btk)
‌
US Patent 10010507 Pharmaceutical formulations of a bruton's tyrosine kinase inhibitor
‌
US Patent 10016435 Use of inhibitors of Bruton's tyrosine kinase (Btk)
‌
US Patent 10213386 Pharmaceutical formulations of a Bruton's tyrosine kinase inhibitor
‌
US Patent 10478439 Use of inhibitors of bruton's tyrosine kinase (Btk)
Patent primary examiner
‌
Umamaheswari Ramachandran

Find more entities like US Patent 10751342 Use of inhibitors of Bruton's tyrosine kinase (Btk)

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo